
Phreesia Inc (PHR) Stock Forecast & Price Target
Phreesia Inc (PHR) Analyst Ratings
Bulls say
Phreesia Inc. demonstrated robust performance in total revenue, achieving a 15.4% year-over-year growth, primarily fueled by a significant increase of 28.5% in network solutions revenue. The company has also effectively expanded its adjusted EBITDA margins, reaching 14.9%, which reflects a substantial turnaround from a negative margin of (3.6%) in the prior year, showcasing efficient operational execution. Furthermore, management's reaffirmation of expectations for increased revenue per account health system client (AHSC) indicates a promising outlook, particularly with the anticipated growth in both new AHSC additions and high-value product monetization through its integrated solutions.
Bears say
Phreesia Inc. is facing significant challenges, highlighted by a flat year-over-year payment-facilitator volume percentage and a sequential decline in its take rate, indicating stagnation in key financial metrics. Additionally, while operating expenses were lower than anticipated, higher than expected payment processing expenses, driven by the transition away from a major client, constrained overall revenue growth, contributing to an estimated payments revenue headwind of $1 million to $2 million in the fourth quarter. The potential risk of declining patient visit volumes due to a resurgence of COVID-19 and increasing competition from vendors poses further threats to Phreesia's financial performance and client retention, warranting a negative outlook.
This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.
Phreesia Inc (PHR) Analyst Forecast & Price Prediction
Start investing in Phreesia Inc (PHR)
Order type
Buy in
Order amount
Est. shares
0 shares